Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
INO80D antisense RNA 1 is a long non-coding RNA gene located antisense to the protein-coding INO80D gene. Like other antisense lncRNAs, INO80D-AS1 may regulate the expression or function of its sense partner gene (INO80D), potentially playing a role in cellular gene regulation. A related lncRNA (CR933609) is shown to act as a decoy to protect INO80D from miRNA-mediated downregulation in non-small cell lung cancer cells, suggesting that antisense or regulatory lncRNAs in this genomic region may influence cancer biology. However, specific biological functions, disease links, and therapeutic relevance of INO80D-AS1 itself remain largely uncharacterized in current biomedical literature. There are no known clinically approved drugs, biomarkers, or direct safety concerns associated with this RNA. In summary, INO80D-AS1 is an antisense lncRNA, not a canonical drug target, and primarily classified under gene regulatory functions with a possible, but yet unconfirmed, role in cancer biology.
None reported — lncRNAs such as INO80D-AS1 are typically not direct drug targets, and no established mechanisms of action for drugs binding or modulating INO80D-AS1 are available.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on INO80D antisense RNA 1 (INO80D-AS1).